Skip Navigational Links
LISTSERV email list manager
LISTSERV - COMMUNITY.LSOFT.COM
LISTSERV Menu
Log In
Log In
LISTSERV 17.5 Help - LACTNET Archives
LISTSERV Archives
LISTSERV Archives
Search Archives
Search Archives
Register
Register
Log In
Log In

LACTNET Archives

Lactation Information and Discussion

LACTNET@COMMUNITY.LSOFT.COM

Menu
LISTSERV Archives LISTSERV Archives
LACTNET Home LACTNET Home

Log In Log In
Register Register

Subscribe or Unsubscribe Subscribe or Unsubscribe

Search Archives Search Archives
Options: Use Forum View

Use Monospaced Font
Show Text Part by Default
Condense Mail Headers

Message: [<< First] [< Prev] [Next >] [Last >>]
Topic: [<< First] [< Prev] [Next >] [Last >>]
Author: [<< First] [< Prev] [Next >] [Last >>]

Print Reply
Sender:
Lactation Information and Discussion <[log in to unmask]>
Subject:
Future ABM
From:
Cynthia Dillon Payne <[log in to unmask]>
Date:
Thu, 25 Sep 1997 16:32:26 -0400
Comments:
To: [log in to unmask]
Reply-To:
Lactation Information and Discussion <[log in to unmask]>
Parts/Attachments:
text/plain (14 lines)
Just received this hidden in the middle of an article about advances in
science since Sputnik.  One more "advance" in ABM we'll have to watch out
for...
Cynthia D. Payne
LLL of Berkshire County Mass
************************************************

    George Hersbach, president and CEO, Pharming Ltd., The Netherlands.
          Before Dolly the cloned sheep, there was Herman the genetically
    engineered bull.  Herman's female offspring produce human lactoferrin,
    a natural antibiotic, for infant formula.  Pharming Ltd.'s first products
could
    be launched in 1999.

ATOM RSS1 RSS2

COMMUNITY.LSOFT.COM CataList Email List Search Powered by LISTSERV